Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric S Daar

Showing results (81-90 of 222) with videos related to

Pageof 23
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|October 19, 2018
Sexual Risk Compensation in a Pre-exposure Prophylaxis Demonstration Study Among Individuals at Risk of HIVJoel Milam, Sonia Jain, Michael P Dubé, et al.
The Journal of Infectious Diseases|November 14, 2012
HIV-1 amino acid changes among participants with virologic failure: associations with first-line efavirenz or atazanavir plus ritonavir and disease statusKatie Mollan, Eric S Daar, Paul E Sax, et al.
The Journal of Antimicrobial Chemotherapy|August 28, 2014
Sex differences in atazanavir pharmacokinetics and associations with time to clinical events: AIDS Clinical Trials Group Study A5202Charles S Venuto, Katie Mollan, Qing Ma, et al.
HIV Clinical Trials|December 17, 2013
Early virologic response to abacavir/lamivudine and tenofovir/emtricitabine during ACTG A5202Philip M Grant, Camlin Tierney, Chakra Budhathoki, et al.
The Journal of Infectious Diseases|August 31, 2023
ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in OutpatientsJudith S Currier, Carlee Moser, Joseph J Eron, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|December 21, 2022
Leveraging Multi-Ancestry Polygenic Risk Scores for Body Mass Index to Predict Antiretroviral Therapy-Induced Weight GainKarl Keat, Daniel Hui, Brenda Xiao, et al.
AIDS and Behavior|May 5, 2018
Randomized Trial of a Health Coaching Intervention to Enhance Retention in Care: California Collaborative Treatment Group 594Katya Corado, Sonia Jain, Sheldon Morris, et al.
Metabolites|October 28, 2025
Association of Intracellular Microstructural and Neuropsychological Changes in HIV: A Pilot Validation of Trace Diffusion-Weighted Magnetic Resonance Spectroscopic Imaging Using Radial TrajectoriesAjin Joy, Andres Saucedo, Matthew J Wright, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 15, 2013
Associations of inflammatory markers with AIDS and non-AIDS clinical events after initiation of antiretroviral therapy: AIDS clinical trials group A5224s, a substudy of ACTG A5202Grace A McComsey, Douglas Kitch, Paul E Sax, et al.
Clinical and Translational Science|September 20, 2019
Real-Time and Wireless Assessment of Adherence to Antiretroviral Therapy With Co-Encapsulated Ingestion Sensor in HIV-Infected Patients: A Pilot StudyEric S Daar, Marc I Rosen, Yan Wang, et al.
Pageof 23

Showing results (81-90 of 222) with videos related to

Sort By:
Pageof 23
Journal of Acquired Immune Deficiency Syndromes (1999)|October 19, 2018
Sexual Risk Compensation in a Pre-exposure Prophylaxis Demonstration Study Among Individuals at Risk of HIVJoel Milam, Sonia Jain, Michael P Dubé, et al.
The Journal of Infectious Diseases|November 14, 2012
HIV-1 amino acid changes among participants with virologic failure: associations with first-line efavirenz or atazanavir plus ritonavir and disease statusKatie Mollan, Eric S Daar, Paul E Sax, et al.
The Journal of Antimicrobial Chemotherapy|August 28, 2014
Sex differences in atazanavir pharmacokinetics and associations with time to clinical events: AIDS Clinical Trials Group Study A5202Charles S Venuto, Katie Mollan, Qing Ma, et al.
HIV Clinical Trials|December 17, 2013
Early virologic response to abacavir/lamivudine and tenofovir/emtricitabine during ACTG A5202Philip M Grant, Camlin Tierney, Chakra Budhathoki, et al.
The Journal of Infectious Diseases|August 31, 2023
ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in OutpatientsJudith S Currier, Carlee Moser, Joseph J Eron, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|December 21, 2022
Leveraging Multi-Ancestry Polygenic Risk Scores for Body Mass Index to Predict Antiretroviral Therapy-Induced Weight GainKarl Keat, Daniel Hui, Brenda Xiao, et al.
AIDS and Behavior|May 5, 2018
Randomized Trial of a Health Coaching Intervention to Enhance Retention in Care: California Collaborative Treatment Group 594Katya Corado, Sonia Jain, Sheldon Morris, et al.
Metabolites|October 28, 2025
Association of Intracellular Microstructural and Neuropsychological Changes in HIV: A Pilot Validation of Trace Diffusion-Weighted Magnetic Resonance Spectroscopic Imaging Using Radial TrajectoriesAjin Joy, Andres Saucedo, Matthew J Wright, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 15, 2013
Associations of inflammatory markers with AIDS and non-AIDS clinical events after initiation of antiretroviral therapy: AIDS clinical trials group A5224s, a substudy of ACTG A5202Grace A McComsey, Douglas Kitch, Paul E Sax, et al.
Clinical and Translational Science|September 20, 2019
Real-Time and Wireless Assessment of Adherence to Antiretroviral Therapy With Co-Encapsulated Ingestion Sensor in HIV-Infected Patients: A Pilot StudyEric S Daar, Marc I Rosen, Yan Wang, et al.
Pageof 23